Pointing the way to a more precise psychiatry – Interview with Dr Hugh Marston

Dr Hugh Marston, head of Global CNS Diseases at Boehringer Ingelheim (BI), is the industry lead on the PRISM project. He discusses the industry perspective with ECNP Press Officer, Tom Parkhill.

Click here to read the full interview.